| Name | Ilaprazole sodium hydrate |
|---|---|
| Synonyms | 1H-Benzimidazole, 2-[[(4-methoxy-3-methyl-2-pyridinyl)methyl]sulfinyl]-6-(1H-pyrrol-1-yl)-, sodium salt, hydrate (1:1:2) |
| Description | Ilaprazole (IY-81149) sodium hydrate is an orally active proton pump inhibitor. Ilaprazole sodium hydrate irreversibly inhibits H+/K+-ATPase in a dose-dependent manner with an IC50 of 6 μM in rabbit parietal cell preparation. Ilaprazole sodium hydrate is used for the research of gastric ulcers. Ilaprazole sodium hydrate is also a potent TOPK (T-lymphokine-activated killer cell-originated protein kinase) inhibitor[1][2]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C19H21N4NaO4S |
|---|---|
| Molecular Weight | 424.45 |